phenytoin has been researched along with Fungal Diseases in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twelve patients receiving therapy with an azole agent (ketoconazole, itraconazole, and/or fluconazole) for systemic mycoses experienced drug interactions with rifampin, phenytoin, and/or carbamazepine resulting in substantial decreases in azole concentrations in serum." | 3.68 | Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations. ( Denning, DW; Graybill, JR; Hanson, LH; Pappagianis, D; Rinaldi, MG; Sharkey, PK; Stevens, DA; Tucker, RM, 1992) |
| "Voriconazole is a first-line agent in the treatment of many invasive fungal infections and is known to display highly variable pharmacokinetics." | 1.38 | Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring. ( Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, LG; Ray, JE, 2012) |
| "Posaconazole has an important role in the prophylaxis and salvage treatment of invasive fungal infections (IFIs), although poor and variable bioavailability remains an important clinical concern." | 1.38 | Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration. ( Chen, SC; Dolton, MJ; McLachlan, AJ; Ng, K; Pont, L; Ray, JE, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dolton, MJ | 2 |
| Ray, JE | 2 |
| Chen, SC | 2 |
| Ng, K | 2 |
| Pont, LG | 1 |
| McLachlan, AJ | 2 |
| Pont, L | 1 |
| Tucker, RM | 1 |
| Denning, DW | 1 |
| Hanson, LH | 1 |
| Rinaldi, MG | 1 |
| Graybill, JR | 1 |
| Sharkey, PK | 1 |
| Pappagianis, D | 1 |
| Stevens, DA | 1 |
3 other studies available for phenytoin and Fungal Diseases
| Article | Year |
|---|---|
Multicenter study of voriconazole pharmacokinetics and therapeutic drug monitoring.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Australia; Drug Interact | 2012 |
Multicenter study of posaconazole therapeutic drug monitoring: exposure-response relationship and factors affecting concentration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Australia; Dose-Response Relationship | 2012 |
Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Topics: Adult; Aged; Antifungal Agents; Azoles; Carbamazepine; Coccidioides; Cryptococcus neoformans; Drug I | 1992 |